Beta-lactamase induction and cell wall metabolism in Gram-negative bacteria

Frontiers in Microbiology

Volumn 4, Issue MAY, 2013, Pages

  Zeng, Ximin ^a   Lin, Jun ^a  

^a University of Tennessee Health Sciences Center   (United States)

Author keywords

Beta lactamase; Peptidoglycan; Regulation

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CEFTAZIDIME; CEPHALOSPORIN; GAMMA GLUTAMYLTRANSFERASE; GLYCOSYLTRANSFERASE; MONOBACTAM DERIVATIVE; N ACETYLGLUCOSAMINE THIAZOLINE; PENICILLIN DERIVATIVE; PEPTIDOGLYCAN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; CELL MEMBRANE TRANSPORT; CELL METABOLISM; CELL WALL; GRAM NEGATIVE BACTERIUM; GROWTH RATE; HUMAN; LIMIT OF DETECTION; NONHUMAN; OSMOTIC PRESSURE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PUBLIC HEALTH PROBLEM; SIGNAL TRANSDUCTION;

NEGIBACTERIA;

EID: 84884278616     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2013.00128     Document Type: Article

References (107)

1. Abraham, E. P., and Chain, E. (1940). An enzyme from bacteria able to destroy penicillin. Nature 146, 837-837.
2. Alksne, L. E., and Rasmussen, B. A. (1997). Expression of the AsbA1, OXA-12, and AsbM1 beta-lactamases in Aeromonas jandaei AER 14 is coordinated by a twocomponent regulon. J. Bacteriol. 179, 2006-2013.
3. Ambler, R. P. (1980). The structure of beta-lactamases. Philos. Trans. R. Soc. Lond. B Biol. Sci. 289, 321-331.
4. Amemura, M., Makino, K., Shinagawa, H., and Nakata, A. (1986). Nucleotide sequence of the phoM region of Escherichia coli: four open reading frames may constitute an operon. J. Bacteriol. 168, 294-302.
5. Amoroso, A., Boudet, J., Berzigotti, S., Duval, V., Teller, N., Mengin-Lecreulx, D., et al. (2012). A peptidoglycan fragment triggers β-lactam resistance in Bacillus licheniformis. PLoS Pathog. 8:e1002571. doi: 10.1371/journal.ppat.1002571
6. Armstrong, G. L., Conn, L. A., and Pinner, R. W. (1999). Trends in infectious disease mortality in the United States during the 20th century. JAMA 281, 61-66.
7. Avison, M. B., Horton, R. E., Walsh, T. R., and Bennett, P. M. (2001). Escherichia coli CreBC is a global regulator of gene expression that responds to growth in minimal media. J. Biol. Chem. 276, 26955-26961.
8. Avison, M. B., Niumsup, P., Nurmahomed, K., Walsh, T. R., and Bennett, P. M. (2004). Role of the 'cre/blr-tag' DNA sequence in regulation of gene expression by the Aeromonas hydrophila beta-lactamase regulator, BlrA. J. Antimicrob. Chemother. 53, 197-202.
9. Avison, M. B., Niumsup, P., Walsh, T. R., and Bennett, P. M. (2000). Aeromonas hydrophila AmpH and CepH beta-lactamases: derepressed expression in mutants of Escherichia coli lacking creB. J. Antimicrob. Chemother. 46, 695-702.
10. Balasubramanian, D., Schneper, L., Merighi, M., Smith, R., Narasimhan, G., Lory, S., et al. (2012). The regulatory repertoire of Pseudomonas aeruginosa AmpC β- lactamase regulator AmpR includes virulence genes. PLoS ONE 7:e34067. doi: 10.1371/journal.pone.0034067
11. Barnaud, G., Arlet, G., Verdet, C., Gaillot, O., Lagrange, P. H., and Philippon, A. (1998). Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob. Agents Chemother. 42, 2352-2358.
12. Barreteau, H., Kovac, A., Boniface, A., Sova, M., Gobec, S., and Blanot, D. (2008). Cytoplasmic steps of peptidoglycan biosynthesis. FEMS Microbiol. Rev. 32, 168- 207.
13. Bartowsky, E., and Normark, S. (1991). Purification and mutant analysis of Citrobacter freundii AmpR, the regulator for chromosomal AmpC beta-lactamase. Mol. Microbiol. 5, 1715-1725.
14. Bergstrom, S., Olsson, O., and Normark, S. (1982). Common evolutionary origin of chromosomal beta-lactamase genes in enterobacteria. J. Bacteriol. 150, 528-534.
15. Bonis, M., Williams, A., Guadagnini, S., Werts, C., and Boneca, I. G. (2012). The effect of bulgecin A on peptidoglycan metabolism and physiology of Helicobacter pylori. Microb. Drug Resist. 18, 230-239.
16. Bou, G., and Martinez-Beltran, J. (2000). Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 44, 428-432.
17. Bouhss, A., Trunkfield, A. E., Bugg, T. D., and Mengin-Lecreulx, D. (2008). The biosynthesis of peptidoglycan lipid-linked intermediates. FEMS Microbiol. Rev. 32, 208-233.
18. Bush, K., and Macielag, M. J. (2010). New β-lactam antibiotics and β-lactamase inhibitors. Expert Opin. Ther. Pat. 20, 1277-1293.
19. Capra, E. J., and Laub, M. T. (2012). Evolution of two-component signal transduction systems. Annu. Rev. Microbiol. 66, 325-347.
20. Cheng, Q., Li, H., Merdek, K., and Park, J. T. (2000). Molecular characterization of the beta-N-acetylglucosaminidase of Escherichia coli and its role in cell wall recycling. J. Bacteriol. 182, 4836-4840.
21. Cheng, Q., and Park, J. T. (2002). Substrate specificity of the AmpG permease required for recycling of cell wall anhydro-muropeptides. J. Bacteriol. 184, 6434- 6436.
22. Clarke, C. A., Scheurwater, E. M., and Clarke, A. J. (2010). The vertebrate lysozyme inhibitor Ivy functions to inhibit the activity of lytic transglycosylase. J. Biol. Chem. 285, 14843-14847.
23. Cloud-Hansen, K. A., Peterson, S. B., Stabb, E. V., Goldman, W. E., Mcfall-Ngai, M. J., and Handelsman, J. (2006). Breaching the great wall: peptidoglycan and microbial interactions. Nat. Rev. Microbiol. 4, 710-716.
24. Cohen, M. L. (2000). Changing patterns of infectious disease. Nature 406, 762-767.
25. Cooper, P. D. (1955). The site of action of penicillin: some properties of the penicillin-binding component of Staphylococcus aureus. J. Gen. Microbiol. 12, 100-106.
26. Cooper, P. D., Rowley, D., and Dawson, I. M. (1949). Location of radioactive penicillin in Staphylococcus aureus after contact with the drug. Nature 164, 842.
27. Culotta, E. (1994). Funding crunch hobbles antibiotic resistance research. Science 264, 362-363.
28. de Pedro, M. A., Donachie, W. D., Holtje, J. V., and Schwarz, H. (2001). Constitutive septal murein synthesis in Escherichia coli with impaired activity of the morphogenetic proteins RodA and penicillin-binding protein 2. J. Bacteriol. 183, 4115-4126.
29. Dziarski, R., and Gupta, D. (2005). Staphylococcus aureus peptidoglycan is a Toll-like receptor 2 activator: a reevaluation. Infect. Immun. 73, 5212-5216.
30. Eriksson-Grennberg, K. G. (1968). Resistance of Escherichia coli to penicillins. II. An improved mapping of the ampA gene. Genet Res. 12, 147-156.
31. Eriksson-Grennberg, K. G., Boman, H. G., Jansson, J. A. T., and Thoren, S. (1965). Resistance of Escherichia coli to penicillins. I. Genetic study of some ampicillinresistant mutants. J. Bacteriol. 90, 54-62.
32. Fernandez, A., Perez, A., Ayala, J. A., Mallo, S., Rumbo-Feal, S., Tomas, M., et al. (2012). Expression of OXA-type and SFO-1 beta-lactamases induces changes in peptidoglycan composition and affects bacterial fitness. Antimicrob. Agents Chemother. 56, 1877-1884.
33. Fleming, A. (1929). On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenza. Br. J. Exp. Pathol. 10, 226-236.
34. Fuda, C., Suvorov, M., Vakulenko, S. B., and Mobashery, S. (2004). The basis for resistance to beta-lactam antibiotics by penicillin-binding protein 2a of methicillinresistant Staphylococcus aureus. J. Biol. Chem. 279, 40802-40806.
35. Fuda, C. C., Fisher, J. F., and Mobashery, S. (2005). Beta-lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome. Cell. Mol. Life Sci. 62, 2617-2633.
36. Girlich, D., Kolb, A., Naas, T., and Nordmann, P. (2009). Characterization of regulatory element Rp3 of regulation of beta-lactamases from Ralstonia pickettii. FEMS Microbiol. Lett. 301, 50-56.
37. Girlich, D., Naas, T., and Nordmann, P. (2006). Regulation of class D beta-lactamase gene expression in Ralstonia pickettii. Microbiology 152, 2661-2672.
38. Giwercman, B., Lambert, P. A., Rosdahl, V. T., Shand, G. H., and Hoiby, N. (1990). Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains. J. Antimicrob. Chemother. 26, 247-259.
39. Glauner, B. (1988). Separation and quantification of muropeptides with high-performance liquid chromatography. Anal. Biochem. 172, 451-464.
40. Glauner, B., Holtje, J. V., and Schwarz, U. (1988). The composition of the murein of Escherichia coli. J. Biol. Chem. 263, 10088-10095.
41. Goffin, C., and Ghuysen, J. M. (1998). Multimodular penicillin-binding proteins: an enigmatic family of orthologs and paralogs. Microbiol. Mol. Biol. Rev. 62, 1079- 1093.
42. Goffin, C., and Ghuysen, J. M. (2002). Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent. Microbiol. Mol. Biol. Rev. 66, 702-738
43. Goldman, W. E., Klapper, D. G., and Baseman, J. B. (1982). Detection, isolation, and analysis of a released Bordetella pertussis product toxic to cultured tracheal cells. Infect. Immun. 36, 782-794.
44. Hamad, B. (2010). The antibiotics market. Nat. Rev. Drug Discov. 9, 675-676.
45. Harris, P. N., and Ferguson, J. K. (2012). Antibiotic therapy for inducible AmpC beta-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides? Int. J. Antimicrob. Agents 40, 297-305.
46. Hirakawa, H., Nishino, K., Yamada, J., Hirata, T., and Yamaguchi, A. (2003). Beta-lactam resistance modulated by the overexpression of response regulators of twocomponent signal transduction systems in Escherichia coli. J. Antimicrob. Chemother. 52, 576-582.
47. Holtje, J. V., Kopp, U., Ursinus, A., and Wiedemann, B. (1994). The negative regulator of beta-lactamase induction AmpD is a N-acetyl-anhydromuramyl-L-alanine amidase. FEMS Microbiol. Lett. 122, 159-164.
48. Honore, N., Nicolas, M. H., and Cole, S. T. (1986). Inducible cephalosporinase production in clinical isolates of Enterobacter cloacae is controlled by a regulatory gene that has been deleted from Escherichia coli. EMBO J. 5, 3709-3714.
49. Imada, A., Kintaka, K., Nakao, M., and Shinagawa, S. (1982). Bulgecin, a bacterial metabolite which in concert with beta-lactam antibiotics causes bulge formation. J. Antibiot. (Tokyo) 35, 1400-1403
50. Jacobs, C., Frere, J. M., and Normark, S. (1997). Cytosolic intermediates for cell wall biosynthesis and degradation control inducible beta-lactam resistance in gramnegative bacteria. Cell 88, 823-832.
51. Jacobs, C., Huang, L. J., Bartowsky, E., Normark, S., and Park, J. T. (1994). Bacterial cell wall recycling provides cytosolic muropeptides as effectors for betalactamase induction. EMBO J. 13, 4684-4694.
52. Jacoby, G. A. (2009). AmpC beta-lactamases. Clin. Microbiol. Rev 22, 161-182
53. Jacoby, G. A., and Munoz-Price, L. S. (2005). The new beta-lactamases. N. Engl. J. Med. 352, 380-391.
54. Jaurin, B., and Grundstrom, T. (1981). ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type. Proc. Natl. Acad. Sci. U.S.A. 78, 4897-4901.
55. Jaurin, B., Grundstrom, T., Edlund, T., and Normark, S. (1981). The E. coli beta-lactamase attenuator mediates growth rate-dependent regulation. Nature 290, 221- 225.
56. Jovetic, S., Zhu, Y., Marcone, G. L., Marinelli, F., and Tramper, J. (2010). beta-Lactam and glycopeptide antibiotics: first and last line of defense? Trends Biotechnol. 28, 596-604.
57. Juan, C., Gutierrez, O., Oliver, A., Ayestaran, J. I., Borrell, N., and Perez, J. L. (2005). Contribution of clonal dissemination and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit setting. Clin. Microbiol. Infect. 11, 887-892.
58. Juan, C., Moya, B., Perez, J. L., and Oliver, A. (2006). Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level beta-lactam resistance involves three AmpD homologues. Antimicrob. Agents Chemother. 50, 1780-1787.
59. Kogut, M., Pollock, M. R., and Tridgell, E. J. (1956). Purification of penicillin-induced penicillinase of Bacillus cereus NRRL 569: a comparison of its properties with those of a similarly purified penicillinase produced spontaneously by a constitutive mutant strain. Biochem. J. 62, 391-401.
60. Kohler, T., Michea-Hamzehpour, M., Epp, S. F., and Pechere, J. C. (1999). Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems. Antimicrob. Agents Chemother. 43, 424-427.
61. Kong, K. F., Jayawardena, S. R., Indulkar, S. D., Del Puerto, A., Koh, C. L., Hoiby, N., et al. (2005). Pseudomonas aeruginosa AmpR is a global transcriptional factor that regulates expression of AmpC and PoxB beta-lactamases, proteases, quorum sensing, and other virulence factors. Antimicrob. Agents Chemother. 49, 4567- 4575.
62. Korfmann, G., and Wiedemann, B. (1988). Genetic control of beta-lactamase production in Enterobacter cloacae. Rev. Infect. Dis. 10, 793-799.
63. Korsak, D., Liebscher, S., and Vollmer, W. (2005). Susceptibility to antibiotics and beta-lactamase induction in murein hydrolase mutants of Escherichia coli. Antimicrob. Agents Chemother. 49, 1404-1409.
64. Kraft, A. R., Prabhu, J., Ursinus, A., and Holtje, J. V. (1999). Interference with murein turnover has no effect on growth but reduces beta-lactamase induction in Escherichia coli. J. Bacteriol. 181, 7192-7198.
65. Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., et al. (2010). Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10, 597-602.
66. Leung, A. K., Duewel, H. S., Honek, J. F., and Berghuis, A. M. (2001). Crystal structure of the lytic transglycosylase from bacteriophage lambda in complex with hexa -N-acetylchitohexaose. Biochemistry 40, 5665-5673.
67. Lindquist, S., Lindberg, F., and Normark, S. (1989). Binding of the Citrobacter freundii AmpR regulator to a single DNA site provides both autoregulation and activation of the inducible ampC beta-lactamase gene. J. Bacteriol. 171, 3746-3753.
68. Linstrom, E. B., Boman, H. G., and Steele, B. B. (1970). Resistance of Escherichia coli to penicillins. VI. Purification and characterization of the chromosomally mediated penicillinase present in ampA-containing strains. J. Bacteriol. 101, 218-231.
69. Livermore, D. M. (1987). Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods. Eur. J. Clin. Microbiol. 6, 439-445.
70. Lodge, J. M., Minchin, S. D., Piddock, L. J., and Busby, S. J. (1990). Cloning, sequencing and analysis of the structural gene and regulatory region of the Pseudomonas aeruginosa chromosomal ampC beta-lactamase. Biochem. J. 272, 627-631.
71. Lomovskaya, O., and Bostian, K. A. (2006). Practical applications and feasibility of efflux pump inhibitors in the clinic - a vision for applied use. Biochem. Pharmacol. 71, 910-918.
72. Maass, E. A., and Johnson, M. J. (1949a). Penicillin uptake by bacterial cells. J. Bacteriol. 57, 415-422.
73. Maass, E. A., and Johnson, M. J. (1949b). The relations between bound penicillin and growth in Staphylococcus aureus. J. Bacteriol. 58, 361-366.
74. Mahlen, S. D., Morrow, S. S., Abdalhamid, B., and Hanson, N. D. (2003). Analyses of ampC gene expression in Serratia marcescens reveal new regulatory properties. J. Antimicrob. Chemother. 51, 791-802.
75. Markov, K. I., Saev, G. K., and Ilkov, T. (1960). Investigations with the aid of radioactive isotopes of the effect of penicillin on metabolic processes in penicillinresistant staphylococci. Suvr. Med. (Sofiia) 11, 3-8.
76. Massova, I., and Mobashery, S. (1998). Kinship and diversification of bacterial penicillin-binding proteins and beta-lactamases. Antimicrob. Agents Chemother. 42, 1 -17.
77. Melly, M. A., Mcgee, Z. A., and Rosenthal, R. S. (1984). Ability of monomeric peptidoglycan fragments from Neisseria gonorrhoeae to damage human fallopian-tube mucosa. J. Infect. Dis. 149, 378-386.
78. Morosini, M. I., Ayala, J. A., Baquero, F., Martinez, J. L., and Blazquez, J. (2000). Biological cost of AmpC production for Salmonella enterica serotype Typhimurium. Antimicrob. Agents Chemother. 44, 3137-3143.
79. Moya, B., Dotsch, A., Juan, C., Blazquez, J., Zamorano, L., Haussler, S., et al. (2009). β-Lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein. PLoS Pathog. 5:e1000353. doi: 10.1371/journal.ppat.1000353
80. Nakao, M., Yukishige, K., Kondo, M., and Imada, A. (1986). Novel morphological changes in gram-negative bacteria caused by combination of bulgecin and cefmenoxime. Antimicrob. Agents Chemother. 30, 414-417.
81. Niumsup, P., Simm, A. M., Nurmahomed, K., Walsh, T. R., Bennett, P. M., and Avison, M. B. (2003). Genetic linkage of the penicillinase gene, amp, and blrAB, encoding the regulator of beta-lactamase expression in Aeromonas spp. J. Antimicrob. Chemother. 51, 1351-1358.
82. Ogawara, H. (1981). Antibiotic resistance in pathogenic and producing bacteria, with special reference to beta-lactam antibiotics. Microbiol. Rev. 45, 591-619.
83. Park, J. T., and Uehara, T. (2008). How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan). Microbiol. Mol. Biol. Rev. 72, 211-227
84. Pollock, M. R. (1965). Purification and properties of penicillinases from two strains of Bacillus licheniformis: a chemical, physicochemical and physiological comparison. Biochem. J. 94, 666-675.
85. Reid, C. W., Blackburn, N. T., and Clarke, A. J. (2004a). The effect of NAG-thiazoline on morphology and surface hydrophobicity of Escherichia coli. FEMS Microbiol. Lett. 234, 343-348.
86. Reid, C. W., Blackburn, N. T., Legaree, B. A., Auzanneau, F. I., and Clarke, A. J. (2004b). Inhibition of membrane-bound lytic transglycosylase B by NAG-thiazoline. FEBS Lett. 574, 73-79.
87. Richmond, M. H. (1963). Purification and properties of the exopenicillinase from Staphylococcus aureus. Biochem. J. 88, 452-459.
88. Richmond, M. H. (1965). Wild-type variants of exopenicillinase from Staphylococcus aureus. Biochem. J. 94, 584-593.
89. Safo, M. K., Zhao, Q., Ko, T. P., Musayev, F. N., Robinson, H., Scarsdale, N., et al. (2005). Crystal structures of the BlaI repressor from Staphylococcus aureus and its complex with DNA: insights into transcriptional regulation of the bla and mec operons. J. Bacteriol. 187, 1833-1844.
90. Sanders, C. C. (1987). Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics. Annu. Rev. Microbiol. 41, 573-593.
91. Sauvage, E., Kerff, F., Terrak, M., Ayala, J. A., and Charlier, P. (2008). The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol. Rev. 32, 234-258.
92. Schepartz, S. A., and Johnson, M. J. (1956). The nature of the binding of penicillin by bacterial cells. J. Bacteriol. 71, 84-90.
93. Spratt, B. G., and Pardee, A. B. (1975). Penicillin-binding proteins and cell shape in E. coli. Nature 254, 516-517.
94. Strober, W., Murray, P. J., Kitani, A., and Watanabe, T. (2006). Signalling pathways and molecular interactions of NOD1 and NOD2. Nat. Rev. Immunol. 6, 9-20.
95. Stubbs, K. A., Balcewich, M., Mark, B. L., and Vocadlo, D. J. (2007). Small molecule inhibitors of a glycoside hydrolase attenuate inducible AmpC-mediated betalactam resistance. J. Biol. Chem. 282, 21382-21391.
96. Templin, M. F., Edwards, D. H., and Holtje, J. V. (1992). A murein hydrolase is the specific target of bulgecin in Escherichia coli. J. Biol. Chem. 267, 20039-20043.
97. Thunnissen, A. M., Rozeboom, H. J., Kalk, K. H., and Dijkstra, B. W. (1995). Structure of the 70-kDa soluble lytic transglycosylase complexed with bulgecin A. Implications for the enzymatic mechanism. Biochemistry 34, 12729-12737.
98. Tipper, D. J., and Strominger, J. L. (1965). Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine. Proc. Natl. Acad. Sci. U.S.A. 54, 1133-1141.
99. van Heijenoort, J. (2001a). Formation of the glycan chains in the synthesis of bacterial peptidoglycan. Glycobiology 11, 25R-36R.
100. van Heijenoort, J. (2001b). Recent advances in the formation of the bacterial peptidoglycan monomer unit. Nat. Prod. Rep. 18, 503-519.
101. van Heijenoort, J. (2011). Peptidoglycan hydrolases of Escherichia coli. Microbiol. Mol. Biol. Rev. 75, 636-663.
102. Viala, J., Chaput, C., Boneca, I. G., Cardona, A., Girardin, S. E., Moran, A. P., et al. (2004). Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5, 1166-1174.
103. Votsch, W., and Templin, M. F. (2000). Characterization of a beta-N-acetylglucosaminidase of Escherichia coli and elucidation of its role in muropeptide recycling and beta-lactamase induction. J. Biol. Chem. 275, 39032-39038.
104. Wanner, B. L., and Wilmes-Riesenberg, M. R. (1992). Involvement of phosphotransacetylase, acetate kinase, and acetyl phosphate synthesis in control of the phosphate regulon in Escherichia coli. J. Bacteriol. 174, 2124-2130.
105. Watanabe, T., Kitani, A., Murray, P. J., and Strober, W. (2004). NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5, 800-808.
106. Zhang, Y., Bao, Q., Gagnon, L. A., Huletsky, A., Oliver, A., Jin, S., et al. (2010). ampG gene of Pseudomonas aeruginosa and its role in beta-lactamase expression. Antimicrob. Agents Chemother. 54, 4772-4779.
107. Zhu, Y., Englebert, S., Joris, B., Ghuysen, J. M., Kobayashi, T., and Lampen, J. O. (1992). Structure, function, and fate of the BlaR signal transducer involved in induction of beta-lactamase in Bacillus licheniformis. J. Bacteriol. 174, 6171-6178.